IPP Bureau
Orbicular, Apotex win tentative USFDA nod for generic Ozempic
By IPP Bureau - April 11, 2026
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
ISDE India Edition 2026 spotlights minimally invasive therapies for esophageal cancer
By IPP Bureau - April 11, 2026
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
Mumbai’s Apex Hospital achieves landmark 607 knee replacement surgeries in FY26
By IPP Bureau - April 11, 2026
The event also featured discussions on emerging trends in joint replacement surgery
Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
By IPP Bureau - April 11, 2026
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
Zydus improves ESG rating to 68, up from 66 last year
By IPP Bureau - April 11, 2026
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
CHRI, PATH and GSK Cares launch AMR Safe Disposal Innovation Challenge 2026
By IPP Bureau - April 11, 2026
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Glycomine completes enrollment in Phase 2b trial for rare genetic disorder
By IPP Bureau - April 10, 2026
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing
By IPP Bureau - April 10, 2026
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
By IPP Bureau - April 10, 2026
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
VDYNE gets FDA nod to launch pivotal US trial for tricuspid valve device
By IPP Bureau - April 10, 2026
The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026
By IPP Bureau - April 10, 2026
The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies
Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
By IPP Bureau - April 10, 2026
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
Plasmidsaurus expands RNA-Seq in Europe, partners with Genovis for ambient RNA shipping
By IPP Bureau - April 10, 2026
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
SS Innovations unveils battlefield surgery drone system and mobile OR platform at SMRSC 2026
By IPP Bureau - April 10, 2026
The biggest highlight was Project Vimana, a drone-deployed battlefield trauma surgery system engineered to bring life-saving surgical intervention
Experts seek insurance coverage for stroke rehabilitation as recovery costs rise
By IPP Bureau - April 10, 2026
Experts also underscored the growing role of technologies such as tele-neurorehabilitation, robotics, and AI-driven therapies in improving recovery outcomes
